An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma

Imiquimod 5% cream for the treatment of

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion

✍ W. Sterry; T. Ruzicka; E. Herrera; A. Takwale; J. Bichel; K. Andres; L. Ding; M. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB

## Background: Imiquimod 5% cream has been investigated for non-surgical treatment of superficial and nodular basal cell carcinoma (bcc) tumours. ## Objectives: Two studies were conducted to examine the effect of occlusion at low dosing frequencies on the safety and efficacy of topical imiquimod